AzTrials
AzTrials

EmergencyED-RANCT06707558

Italian Data Registry of Patients Undergoing Peripheral Nerve Block Performed in the Emergency Departments

An observational study of Emergency and Point of Care Ultrasound (POCUS), run by Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria at 1 site in Italy.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This data registry aim is to describe the practice of Point-of-Care Ultrasound Guided Regional Anaesthesia (POCUS-GRA) in emergency departments of nosocomial hospitals where, the organizational structure, has already provided for the implementation of peripheral nerve blocks (PNB) in common clinical practice for the… Read more about this study

Who is it for?
Ages 18 years and older
How many people
500 participants
Where
1 siteItaly
Study dates
10 Dec 2024to 31 Dec 2025
How long will I take part?
7 Days
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Approximately 500 patients entering the emergency department with ≤2 trauma fractures are expected to be enrolled, who undergo PNB

Who may be able to join

  • Age ≥18 years;
  • NRS>3
  • Patients with traumatic fractures of ≤2 districts (radiologically confirmed (RX or CT). Districts are:
  • Chest (one hemilateral) Pelvis (one hemilateral) Femur Leg Ankle Foot Shoulder Humerus Forearm Hand/fingers
  • Presence of written informed consent to the study.

Who cannot join

  • Intubated patients
  • Patients with known dementia
  • Patients with delirium (assessed by Confusion Assessment Method)
  • Pregnant patients
  • Patients with allergies to local anesthetics
  • Patients unable to adequately communicate pain

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mirco Leo, Anesthesiologist contact

0131208119

mirco.leo@ospedale.al.it

Italy1 site
  • Clinical Trial Center

    Alessandria

    Clinical Trial Center, 0131206893, clinicaltrialcenter@ospedale.al.it

    Mirco Leo, Anesthesiologist

Other trials in Italy

About this study

This data registry aim is to describe the practice of Point-of-Care Ultrasound Guided Regional Anaesthesia (POCUS-GRA) in emergency departments of nosocomial hospitals where, the organizational structure, has already provided for the implementation of peripheral nerve blocks (PNB) in common clinical practice for the treatment of acute pain due to bone fractures.

Read the detailed description

Pain in emergency departments (EDs) is often inadequately treated. The consequences of inadequate treatment of pain defined as "oligoanalgesia," can have a negative impact on patient outcomes. The main reasons for this include lack of appropriate pathways, incorrect habits and aversion to opioid use. Pain is a symptom present in 78% of patients entering emergency departments, and among the main causes is trauma. A multimodal approach to pain treatment is more effective and minimizes side effects such as nausea, vomiting, and drowsiness due to the use of some drugs such as opioids. Over the past fifteen years, numerous studies have demonstrated the effectiveness of pain treatment using Point-of-Care Ultrasound Guided Regional Anaesthesia (POCUS-GRA) even outside the operating room. This data registry aim is to describe the practice of Point-of-Care Ultrasound Guided Regional Anaesthesia (POCUS-GRA) in emergency departments of nosocomial hospitals where, the organizational structure, has already provided for the implementation of peripheral nerve blocks (PNB) in common clinical practice for the treatment of acute pain due to bone fractures.

Medical subject headings
Emergencies, Acute Pain, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06707558
Study groupRoleWhat they receive
Patients from emergency department undergoing peripheral nerve blockade (PNB)Patients admitted to the emergency department with ≤2 trauma fractures who undergo peripheral nerve blockade (PNB) will be enrolled

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Minimally Clinically Important Difference

    The percentage of patients, relative to the total, in whom the PNB (Peripheral Nerve Block) resulted in a reduction of at least 3 points in the VAS, defined as the MCID (Minimally Clinically Important Difference).

    Measured: One hour after the end of the procedure

Secondary outcomes (5)
  1. Incidence of complications

    The number of complications associated with the procedure, such as: presence of bleeding, pneumothorax, neurological complications, neurological complications, presence of nerve damage.

    Measured: 7 days after the end of the procedure

  2. Time of procedure

    The time required in minutes for the preparation and execution of the PNB

    Measured: At the end of the procedure

  3. Patient satisfaction

    Assessment of patient satisfaction about analgesia according to a 5-point Likert scale item from 1 (very unsatisfied) to 5 (very satisfied)

    Measured: one hour after the end of the procedure

  4. Operator satisfaction

    Assessment of satisfaction of the operator performing fracture reduction According to Likert 5-item scale from 1 (very unsatisfied) to 5 (very satisfied)

    Measured: After the end of the procedure

  5. Pain before the PNB procedure

    Pain assessment before PNB performance, according to the VAS scale, from 0 (no pain) to 10 (worst pain possible)

    Measured: Before the PNB procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2024
  2. Study start10 Dec 2024 (estimated)
  3. Primary completion30 Sep 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
500 participants (estimated)
Target duration
7 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT06707558
Sponsor's protocol ID
ASO.AnRi.24.03
Acronym
ED-RA
Status last verified
Nov 2024
First submitted
25 Nov 2024
Last updated
29 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency and Point of Care Ultrasound (POCUS), run by Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mirco Leo, Anesthesiologist (0131208119, mirco.leo@ospedale.al.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Minimally Clinically Important Difference (time frame: One hour after the end of the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in